Cite
Ledgerwood JE, Hu Z, Costner P, et al. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015;44:112-118doi: 10.1016/j.cct.2015.08.006.
Ledgerwood, J. E., Hu, Z., Costner, P., Yamshchikov, G., Enama, M. E., Plummer, S., Hendel, C. S., Holman, L., Larkin, B., Gordon, I., Bailer, R. T., Poretz, D. M., Sarwar, U., Kabadi, A., Koup, R., Mascola, J. R., Graham, B. S. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary clinical trials, 44112-118. https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood, Julie E, et al. "Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost." Contemporary clinical trials vol. 44 (2015): 112-118. doi: https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12. PMID: 26275339; PMCID: PMC4751067.
Copy
Download .nbib